The Detection of Immunity against WT1 and SMAD4
Humans
Pleural Effusion, Malignant
Epithelial Cell Adhesion Molecule
/ metabolism
CD8-Positive T-Lymphocytes
B7-H1 Antigen
/ metabolism
Hepatitis A Virus Cellular Receptor 2
/ metabolism
WT1 Proteins
Programmed Cell Death 1 Receptor
/ metabolism
Mucin-3
/ metabolism
Pancreatic Neoplasms
/ pathology
Immunoglobulins
/ metabolism
Vaccines
/ metabolism
HLA-A Antigens
Tumor Microenvironment
Smad4 Protein
/ metabolism
EpCAM
WT1
immunological memory
malignant pleura effusion
neoantigen
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
12 Oct 2022
12 Oct 2022
Historique:
received:
29
08
2022
revised:
03
10
2022
accepted:
10
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Malignant pleural effusion (MPE) provides a liquid tumor microenvironment model that includes cancer cells and immune cells. However, the characteristics of tumor antigen-specific CD8
Identifiants
pubmed: 36293034
pii: ijms232012177
doi: 10.3390/ijms232012177
pmc: PMC9602695
pii:
doi:
Substances chimiques
Epithelial Cell Adhesion Molecule
0
B7-H1 Antigen
0
Hepatitis A Virus Cellular Receptor 2
0
WT1 Proteins
0
Programmed Cell Death 1 Receptor
0
Mucin-3
0
Immunoglobulins
0
Vaccines
0
HLA-A Antigens
0
SMAD4 protein, human
0
Smad4 Protein
0
WT1 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : ALP Institute for Regenerative Medicine Inc
ID : None
Organisme : the Program on Open Innovation Platform with Enterprises, Research Institutes, and Academia of the JST
ID : JPMJOP1722
Organisme : JSPS KAKENHI
ID : JP19K07330
Références
Oncoimmunology. 2019 Nov 3;9(1):1684713
pubmed: 32002298
Br J Cancer. 2007 Feb 12;96(3):417-23
pubmed: 17211480
Vaccines (Basel). 2015 Dec 11;3(4):1004-18
pubmed: 26690485
Lung Cancer. 2005 Mar;47(3):361-71
pubmed: 15713519
Nat Rev Dis Primers. 2016 Apr 21;2:16022
pubmed: 27158978
Int J Mol Sci. 2020 Oct 16;21(20):
pubmed: 33081107
Hum Pathol. 2004 Jan;35(1):122-8
pubmed: 14745734
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Nature. 2016 Aug 4;536(7614):91-5
pubmed: 27350335
Gut. 2015 Oct;64(10):1593-604
pubmed: 25608525
Cytojournal. 2022 Jan 31;19:4
pubmed: 35541033
Nat Immunol. 2017 Aug;18(8):940-950
pubmed: 28628092
BMC Res Notes. 2018 Dec 5;11(1):864
pubmed: 30518402
Lancet. 2021 Jan 30;397(10272):375-386
pubmed: 33485464
Biochem Genet. 1993 Aug;31(7-8):321-8
pubmed: 8274138
Sci Immunol. 2022 Apr 22;7(70):eabn1889
pubmed: 35452256
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Clin Exp Immunol. 2016 Oct;186(1):106-14
pubmed: 27447482
Surg Case Rep. 2020 Sep 25;6(1):222
pubmed: 32975612
Lung Cancer. 2017 May;107:36-40
pubmed: 27168021
Oncoimmunology. 2016 Aug 3;5(9):e1211219
pubmed: 27757304
Immunity. 2018 Feb 20;48(2):214-226
pubmed: 29466754
J Exp Med. 2019 Sep 2;216(9):2128-2149
pubmed: 31227543
Int J Mol Sci. 2020 Aug 27;21(17):
pubmed: 32867034
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Cancer Immunol Immunother. 2017 Jun;66(6):765-776
pubmed: 28289860
Cancer Sci. 2018 Mar;109(3):542-549
pubmed: 29288513
Chem Soc Rev. 2017 Apr 18;46(8):2038-2056
pubmed: 28393954
Clin Cancer Res. 2012 Nov 15;18(22):6339-47
pubmed: 22991414
Oncotarget. 2016 Apr 26;7(17):24677-87
pubmed: 27013581
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Nat Rev Immunol. 2020 Mar;20(3):173-185
pubmed: 31676858
Front Oncol. 2021 Sep 22;11:731175
pubmed: 34631560
Signal Transduct Target Ther. 2021 Jul 5;6(1):249
pubmed: 34219130
Vaccines (Basel). 2020 Dec 24;9(1):
pubmed: 33374342
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
J Immunother. 2015 Jan;38(1):1-11
pubmed: 25415283
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32699181
Nat Biomed Eng. 2018 Aug;2(8):566-569
pubmed: 31015635